eHealth, Inc. (NASDAQ:EHTH – Get Free Report) Director Francis Soistman, Jr. sold 20,306 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $0.70, for a total value of $14,214.20. Following the completion of the transaction, the director directly owned 994,915 shares in the company, valued at approximately $696,440.50. This trade represents a 2.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
eHealth Trading Down 3.1%
Shares of NASDAQ:EHTH traded down $0.02 during midday trading on Friday, reaching $0.67. 204,561 shares of the company’s stock were exchanged, compared to its average volume of 508,759. The firm’s 50 day simple moving average is $1.09 and its two-hundred day simple moving average is $1.42. The company has a debt-to-equity ratio of 0.21, a current ratio of 5.12 and a quick ratio of 5.12. The stock has a market cap of $21.46 million, a price-to-earnings ratio of -0.58 and a beta of 1.63. eHealth, Inc. has a fifty-two week low of $0.67 and a fifty-two week high of $5.89.
eHealth (NASDAQ:EHTH – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The financial services provider reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by ($0.34). eHealth had a net margin of 5.42% and a return on equity of 6.13%. The company had revenue of $33.57 million during the quarter, compared to analysts’ expectations of $33.28 million. As a group, sell-side analysts forecast that eHealth, Inc. will post 0.8 EPS for the current fiscal year.
Hedge Funds Weigh In On eHealth
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. UBS Group lowered their price objective on shares of eHealth from $2.00 to $1.75 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. Royal Bank Of Canada cut their target price on eHealth from $3.00 to $2.00 and set a “sector perform” rating on the stock in a research report on Tuesday, August 25th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of eHealth in a research note on Thursday, August 13th. Five investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $2.19.
View Our Latest Stock Analysis on eHealth
eHealth Company Profile
eHealth, Inc (NASDAQ:EHTH) operates an online health insurance marketplace that helps consumers compare, research and enroll in health insurance and related coverage. Through its digital platforms, the company provides information about available plans, eligibility and benefits, and connects individuals with insurance products offered by a range of carriers.
The company’s offerings primarily include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as individual and family health insurance plans available through public and private marketplaces.
Further Reading
- Five stocks we like better than eHealth
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for eHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eHealth and related companies with MarketBeat.com's FREE daily email newsletter.
